-+ 0.00%
-+ 0.00%
-+ 0.00%

Lipocine Q1 EPS $(0.35) Beats $(0.41) Estimate, Sales $93.86K Miss $370.00K Estimate

Benzinga·05/08/2025 12:10:05
Listen to the news
Lipocine (NASDAQ:LPCN) reported quarterly losses of $(0.35) per share which beat the analyst consensus estimate of $(0.41) by 14.63 percent. This is a 153.03 percent decrease over earnings of $0.66 per share from the same period last year. The company reported quarterly sales of $93.86 thousand which missed the analyst consensus estimate of $370.00 thousand by 74.63 percent. This is a 98.77 percent decrease over sales of $7.62 million the same period last year.